Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization- a correlative study with urine PCA3 and TMPRSS2-ERG

被引：26
|
作者：
Warrick, Joshua I. [1 ]
Tomlins, Scott A. [1 ,2 ,3 ,4 ]
Carskadon, Shannon L. [1 ,2 ]
Young, Allison M. [1 ]
Siddiqui, Javed [1 ,2 ]
Wei, John T. [4 ]
Chinnaiyan, Arul M. [1 ,2 ,3 ,4 ,5 ]
Kunju, Lakshmi P. [1 ,2 ,3 ]
Palanisamy, Nallasivam [1 ,2 ,3 ]
机构：
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48104 USA
[2] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷 / 04期
基金：
美国国家卫生研究院;
关键词：
PCA3; prostate cancer; RNA in situ hybridization; ANTIBODY-BASED DETECTION; ETS GENE FUSIONS; INTRAEPITHELIAL NEOPLASIA; ANTIGEN; REARRANGEMENT STATUS; TMPRSS2/ERG; CARCINOMA; DD3;
D O I：
10.1038/modpathol.2013.169
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PCA3 is a prostate-specific non-coding RNA, with utility as a urine-based early detection biomarker. Here, we report the evaluation of tissue PCA3 expression by RNA in situ hybridization in a cohort of 41 mapped prostatectomy specimens. We compared tissue PCA3 expression with tissue level ERG expression and matched pre-prostatectomy urine PCA3 and TMPRSS2-ERG levels. Across 136 slides containing 138 foci of prostate cancer, PCA3 was expressed in 55% of cancer foci and 71% of high-grade prostatic intraepithelial neoplasia foci. Overall, the specificity of tissue PCA3 was >90% for prostate cancer and high-grade prostatic intraepithelial neoplasia combined. Tissue PCA3 cancer expression was not significantly associated with urine PCA3 expression. PCA3 and ERG positivity in cancer foci was positively associated (P<0.01). We report the first comprehensive assessment of PCA3 expression in prostatectomy specimens, and find limited correlation between tissue PCA3 and matched urine in prostate cancer.
引用
收藏
页码：609 / 620
页数：12
相关论文
共 50 条
  • [1] Correlation of Urine TMPRSS2:ERG and PCA3 to ERG plus and Total Prostate Cancer Burden
    Young, Allison
    Palanisamy, Nallasivam
    Siddiqui, Javed
    Wood, David P.
    Wei, John T.
    Chinnaiyan, Arul M.
    Kunju, Lakshmi P.
    Tomlins, Scott A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (05) : 685 - 696
  • [2] PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
    Warli, Syah Mirsya
    Warli, Muhammad Haritsyah
    Prapiska, Fauriski Febrian
    RESEARCH AND REPORTS IN UROLOGY, 2023, 15 : 149 - 155
  • [3] Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
    Tomlins, Scott A.
    Day, John R.
    Lonigro, Robert J.
    Hovelson, Daniel H.
    Siddiqui, Javed
    Kunju, L. Priya
    Dunn, Rodney L.
    Meyer, Sarah
    Hodge, Petrea
    Groskopf, Jack
    Wei, John T.
    Chinnaiyan, Arul M.
    EUROPEAN UROLOGY, 2016, 70 (01) : 45 - 53
  • [4] Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
    Leyten, Gisele H. J. M.
    Hessels, Daphne
    Jannink, Sander A.
    Smit, Frank P.
    de Jong, Hans
    Cornel, Erik B.
    de Reijke, Theo M.
    Vergunst, Henk
    Kil, Paul
    Knipscheer, Ben C.
    van Oort, Inge M.
    Mulders, Peter F. A.
    Hulsbergen-van de Kaa, Christina A.
    Schalken, Jack A.
    EUROPEAN UROLOGY, 2014, 65 (03) : 534 - 542
  • [5] Urine PCA3 mRNA level in diagnostic of prostate cancer
    Li, Meifeng
    Zhou, Dong
    Zhang, Weili
    Gao, Song
    Zhou, Xiaoqing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (04) : 864 - 866
  • [6] PSGR and PCA3 as Biomarkers for the Detection of Prostate Cancer in Urine
    Rigau, Marina
    Morote, Juan
    Carmen Mir, Maria
    Ballesteros, Carlos
    Ortega, Israel
    Sanchez, Alex
    Colas, Eva
    Garcia, Marta
    Ruiz, Anna
    Abal, Miguel
    Planas, Jacques
    Reventos, Jaume
    Doll, Andreas
    PROSTATE, 2010, 70 (16) : 1760 - 1767
  • [7] Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
    Robert, Gregoire
    Jannink, Sander
    Smit, Frank
    Aalders, Tilly
    Hessels, Daphne
    Cremers, Ruben
    Mulders, Peter F.
    Schalken, Jack A.
    PROSTATE, 2013, 73 (02) : 113 - 120
  • [8] Comparative Evaluation of Urinary PCA3 and TMPRSS2: ERG Scores and Serum PHI in Predicting Prostate Cancer Aggressiveness
    Tallon, Lucile
    Luangphakdy, Devillier
    Ruffion, Alain
    Colombel, Marc
    Devonec, Marian
    Champetier, Denis
    Paparel, Philippe
    Decaussin-Petrucci, Myriam
    Perrin, Paul
    Vlaeminck-Guillem, Virginie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (08) : 13299 - 13316
  • [9] Urine PCA3 and TMPRSS2: ERG Using Cancer-specific Markers to Detect Cancer
    Tomlins, Scott A.
    EUROPEAN UROLOGY, 2014, 65 (03) : 543 - 545
  • [10] Progensa™ PCA3 test for prostate cancer
    Durand, Xavier
    Moutereau, Stephane
    Xylinas, Evanguelos
    de la Taille, Alexandre
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (02) : 137 - 144
12345